Experimental kallikrein gene therapy in hypertension, cardiovascular and renal diseases

Pharmacological Research

Volumn 35, Issue 6, 1997, Pages 517-522

  Chao, J ^a   Chao, L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Essential hypertension; Gene delivery; High blood pressure; Kallikrein

Indexed keywords

APROTININ; KALLIKREIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESSENTIAL HYPERTENSION; GENE TARGETING; GENE THERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0031172344     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.1997.0179     Document Type: Article

References (25)

1. 1. Margolius HS. Tissue kallikreins and kinins: regulation and roles in hypertensive and diabetic diseases. Annu Rev Pharmacol Toxicol 1989; 29: 343-64.
2. 2. Scicli AG, Carretero OA. Renal kallikrein-kinin system. Kidney Int 1986; 29: 120-30.
3. 3. Margolius HS, Geller R, de Jong W, Pisano JJ, Sjoerdsma A. Altered urinary kallikrein excretion in human hypertension. Lancet 1971; 2: 1063-5.
4. 4. Margolius HS, Horwitz D, Pisano JJ, Keiser HR. Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids. Circ Res 1974; 35: 820-5.
5. 5. Zinner SH, Margolius HS, Rosner B, Kass EH. Stability of blood pressure rank and urinary kallikrein concentration in childhood: an eight year follow-up. Circulation 1978; 58: 908-15.
6. 6. Berry TD, Hasstedt SJ, Hunt SC, Wu LL, Smith JB, Ash KO, Kuida H, Williams RR. A gene for high urinary kallikrein may protect against hypertension in Utah kindreds. Hypertension 1989; 13: 3-8.
7. 7. Ader JL, Pollock DM, Butterfield MI, Arendshorst WJ. Abnormalities in kallikrein excretion in spontaneously hypertensive rats. Am J Physiol 1985; 248: F396-F403.
8. 8. Favaro S, Baggio B, Antonello A, Zen A, Cannella G, Todesco S, Borsatti A. Renal kallikrein content of spontaneously hypertensive rats. Clin Sci Mol Med 1975; 49: 69-71.
9. 9. Margolius HS, Geller R, De Jong W, Pisano JJ, Sjoerdsma A. Altered urinary kallikrein excretion in rats with hypertension. Circ Res 1972; 30: 358-62.
10. 10. Geller RG, Margolius HS, Pisano JJ, Keiser HR. Urinary kallikrein excretion in spontaneously hypertensive rats. Circ Res 1975; 36(Suppl. 1): 103-6.
11. 11. Woodley-Miller C, Chao J, Chao, L. Restriction fragment length polymorphisms mapped in spontaneously hypertensive rats using kallikrein probes. J Hypertens 1989; 7: 865-71.
12. 12. Pravenec M, Kren V, Kunes J, Scicli AG, Carretero OA, Simonet L, Kurtz TW. Cosegregation of blood pressure with a kallikrein gene family polymorphism. Hypertension 1991; 17: 242-6.
13. 13. Wang J, Xiong W, Yang Z, Davis T, Dewey MJ, Chao J, Chao L. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension 1994; 23: 236-43.
14. 14. Chao, J, Chao L. Experimental approaches using kallikrein gene thoeapy for hypertension. In: March KL. ed. Gene Transfer in the Cardiovascular System, Experimental Approaches and Therapeutic Implications. Kluwer Academic Publishers, 1997, pp. 449-73.
15. 15. Overlack A, Stumpe KO, Kolloch R, Ressel C, Krueck F. Antihypertensive effect of orally administered glandular kallikrein in essential hypertension. Results of double blind study. Hypertension 1981; 3: 118-21.
16. 16. Uehara Y, Hirawa N, Kawabata Y, Suzuki T, Ohshima N, Oka K, Ikeda T, Goto A, Toyo-oka T, Kizuki K, Omata M. Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats. Hypertension 1994; 24: 770-78.
17. 17. Glanville N, Durnam DM, Palmiter RD. Structure of mouse metallothionein-I gene and its mRNA. Nature 1981; 292: 267-9.
18. 18. Wang C, Chao L, Chao J. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats. J Clin Invest 1995; 95: 1710-6.
19. 19. Chao J, Jin L, Chen LM, Chen VC, Chao L. Systemic and portal vein delivery of human kallikrein gene reduces blood pressure in hypertensive rats. Hum Gene Ther 1996; 7: 901-11.
20. 20. Xiong W, Chao J, Chao L. Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats. Hypertension 1995; 25: 1-5.
21. 21. Wang, C., Chao, C., Chao, L., Chao, J. Expression of human tissue kallikrein in rat salivary glands and its secretion into circulation following adenovirus-mediated gene delivery. Immunopharmacology 1997; 36: 229-36.
22. 22. Milligan, RC. The basic science of gene therapy. Science 1993; 260: 926-32.
23. 23. Jin L, Chao L, Chao J. Adenovirus-mediated kallikrein gene delivery reduces blood pressure in spontaneously hypertensive rats. Hum Gene Ther (submitted).
24. 24. Yayama K, Wang C, Chao L, Chao J. Kallikrein gene delivery attenuates hypertension/cardiac hypertrophy and enhances renal function in Goldblatt hypertensive rats. (submitted).
25. 25. Chao J, Zhang J, Lin KF, Chao L. Adenovirus-mediated kallikrein gene delivery attenuates hypertension, cardiac hypertrophy and renal injury in Dahl-salt sensitive rats. Hum Gene Ther (submitted).